Priority for Pediatric Cures Act

This bill changes the Federal Food, Drug, and Cosmetic Act so that the Secretary of Health and Human Services can keep awarding priority review vouchers for drugs that treat rare diseases in children, with no end date. A priority review voucher lets a drug company get faster federal review of a future drug application. The bill does this by removing the paragraph in current law that limits how long this voucher program can continue.

Full text and official record on Congress.gov

Sponsors

• Gus M. Bilirakis Republican sponsor
• 9 cosponsors